The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 05, 2025

Filed:

Apr. 24, 2023
Applicant:

Unm Rainforest Innovations, Albuquerque, NM (US);

Inventors:

Angela Wandinger-Ness, Albuquerque, NM (US);

Laurie Hudson, Albuquerque, NM (US);

Larry Sklar, Albuquerque, NM (US);

Zurab Surviladze, Albuquerque, NM (US);

Tudor Oprea, Albuquerque, NM (US);

Assignee:

UNM Rainforest Innovations, Albuquerque, NM (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/407 (2006.01); A61K 31/403 (2006.01); A61K 31/415 (2006.01); A61K 45/06 (2006.01); C07D 231/06 (2006.01); C12Q 1/6886 (2018.01); G01N 33/573 (2006.01);
U.S. Cl.
CPC ...
A61K 31/407 (2013.01); A61K 31/403 (2013.01); A61K 31/415 (2013.01); A61K 45/06 (2013.01); C07D 231/06 (2013.01); C12Q 1/6886 (2013.01); G01N 33/573 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/158 (2013.01); Y02A 50/30 (2018.01);
Abstract

The present invention relates to molecules which function as modulators (i.e., inhibitors and agonists) of the Ras-homologous (Rho) family of small GTPases (e.g. Rac, Cdc42 and Rho GTPases) and their use to treat diseases, including cancers (including solid tumors-medulloblastoma, ovarian, breast, head and neck, testicular, prostate among others and hematologic malignancies-B cell lymphoma, where these GTPases are overexpressed or hyperactivated), sporadic and genetic diseases where activation of Rho GTPases plays a pivotal role (Menkes disease, rheumatoid arthritis, atherosclerosis, diabetes (type I), Huntington's disease and Alzheimer's disease) which are mediated through these proteins. Compounds according to the present invention may also be used as a therapy for the treatment ofspp. orspp. infections, especially including


Find Patent Forward Citations

Loading…